Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 171, Issue 2, 2013, Pages 329-332

  Duhan, Nirmala ^a   Madaan, Shikha ^a   Sen, Jyotsna ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Letrozole; Medical therapy; Uterine myoma

Indexed keywords

ESTRADIOL; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; FEMALE; HOT FLUSH; HUMAN; NAUSEA; PATIENT SATISFACTION; PREMENOPAUSE; PRIORITY JOURNAL; TUMOR VOLUME; UTERUS MYOMA;

LETROZOLE; MEDICAL THERAPY; UTERINE MYOMA;

ADULT; AROMATASE INHIBITORS; FEMALE; HUMANS; LEIOMYOMA; MIDDLE AGED; NITRILES; PREMENOPAUSE; PROSPECTIVE STUDIES; TRIAZOLES; UTERINE NEOPLASMS;

EID: 84890441220     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.09.010     Document Type: Article

References (17)

1. N. Duhan, and D. Sirohiwal Uterine myomas revisited Eur J Obstet Gynecol Reprod Biol 152 2010 119 125
2. P.G. Crosignani, P. Versillini, M. Mechia, S. Odlani, and T. Bramate GnRH agonists before surgery for uterine leiomyomas: a review J Reprod Med 41 1996 415 421
3. V. De Leo, G. Morgate, D. Lanzette, D. D'Antona, and R.S. Bertieri Danazol administration after gonadotropin releasing hormone analogue reduces rebound of uterine myomas Hum Reprod 12 1997 357 360
4. H. Sumitani, M. Shozu, and T. Segawa In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism Endocrinology 141 2000 3852 3860
5. M. Shozu, K. Murakami, and U. Inoue Aromatase and leiomyoma of the uterus Semin Reprod Med 22 2004 55 61
6. A. Buzdar, J. Douma, and N. Davidson Phase III, multicentre, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate J Clin Oncol 19 2001 3357 3366
7. E. Bajetta, N. Zilembo, and C. Noberasco The minimal effective exemestane dose for endocrine activity in advanced breast cancer Eur J Cancer 33 1997 587 591
8. L.B. Michaud, and A.U. Buzdar Risks and benefits of aromatase inhibitors in postmenopausal breast cancer Drug Saf 21 1999 297 309
9. M. Shozu, K. Murakami, T. Segawa, T. Kasai, and M. Inoue Successful treatment of a symptomatic uterine leiomyoma in a premenopausal woman with a non-steroidal aromatase inhibitor Fertil Steril 79 2003 628 631
10. M.E. Parsanezhad, M. Azmoon, and S. Alborzis A randomized controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status Fertil Steril 74 2010 192 198
11. S.G. Hilario, N.A. Bozzini, R.A. Borsari, and E.C. Baracat Action of aromatase inhibitor for treatment of leiomyoma in perimenopausal patients Fertil Steril 91 2009 240 243
12. U. Schumacher, J. Schumacher, U. Mellinger, C. Gerlinger, A. Wienke, and J. Endrikat Estimation of menstrual blood loss volume based on menstrual diary and laboratory data BMC Women's Health 2012 12 24
13. M.F. Mitwally, and R.F. Casper Use of aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate Fertil Steril 75 2001 305 309
14. E.R. Rossi, A. Morabito, and F. Di Rella Endocrine effects of adjuvant letrozole compared with Tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial J Clin Oncol 27 2009 3192 3197
15. S. Kumru, A.A. Yildiz, B. Yilmaz, S. Sandal, and B. Gurates Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats Gynecol Endocrinol 23 2007 556 561
16. A. Llombart, A. Frassoldati, and A. Paija Immediate administration of zoledronic acid reduces aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer: 12-month analysis of the E-ZO-FAST trial Clin Breast Cancer 12 2012 40 48
17. N.J. Bundred Aromatase inhibitors and bone health Curr Opin Obstet Gynecol 21 2009 60 67